| Association of Dietary Carrot/Carotene Intakes With Ovarian Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. |
Hu Xiaoli |
The First Affiliated Hospital of Wenzhou Medical University |
PLCO |
Sep 28, 2022 |
PLCO-1061 |
| Machine Learning Models for Image-Based Diagnosis and Prognosis of Cancer |
Yang Zhao |
Nanjing Medical University |
PLCO |
Sep 28, 2022 |
PLCOI-1058 |
| Associations between lifestyle factors and colorectal cancer in the PLCO Cancer Screening Trial |
Kerrie Nelson |
Boston University |
PLCO |
Sep 21, 2022 |
PLCO-1053 |
| Class Project Reviewing Correlation between PSA and Prostate Cancer |
Mohamed Yaghi |
Mohamed Yaghi |
PLCO |
Sep 20, 2022 |
PLCO-1054 |
| Pretreatment CA125 trajectory combined with Body Mass Index (BMI) trajectory predicts the risk of Epithelial Ovarian Cancer. |
Kun Song |
Department of Obstetrics Gynecology, Qilu Hospital of Shandong University |
PLCO |
Sep 20, 2022 |
PLCO-1055 |
| Multivitamin use and mortality |
Erikka Loftfield |
Erikka Loftfield Cronin |
PLCO |
Sep 19, 2022 |
PLCO-1052 |
| A retrospective study on female-specific characteristics and their association to colorectal cancer using the PLCO Colorectal dataset |
Keerthana Clark |
Eastern Virginia Medical School |
PLCO |
Sep 9, 2022 |
PLCO-1043 |
| Correlates dietary and lifestyle patterns with survival in patients with gastrointestinal cancers |
Christina Grinstead |
University of Florida |
PLCO |
Sep 9, 2022 |
PLCO-1047 |
| Prostate Cancer Cohort Consortium (PC3): A collaborative approach to an enigmatic cancer |
Konrad Stopsack |
Harvard T.H. Chan School of Public Health |
PLCO |
Sep 9, 2022 |
PLCO-1046 |
| Academic Research using Deep Learning of PLCO's Lung data |
zean liu |
Harbin Institute of Technology |
PLCO |
Sep 8, 2022 |
PLCOI-1049 |
| Aflatoxin, Polycyclic Aromatic Hydrocarbons, Heavy metals and DNA Methylation in Hepatocellular Carcinoma |
HuiChen Wu |
Columbia University |
PLCO |
Sep 7, 2022 |
2022-0003 |
| The timing between the diagnosis and the end of the last treatment in the cancer continuum in patients with lung cancer by TNM stages; and the impact of delays in the final survival of the patients, in PLCO, In the period available in the data set. |
Percy Guzman |
NCI |
PLCO |
Sep 6, 2022 |
PLCO-1036 |
| An instrumental-variable method on estimating optimal treatment regime by maximizing t-year survival function |
Xia Junwen |
Renmin University of China |
PLCO |
Sep 6, 2022 |
PLCO-1040 |
| Ethnicity bias in automated chest X-ray classification |
Giovanni Montana |
University of Warwick |
PLCO |
Sep 6, 2022 |
PLCOI-1042 |
| Post-diagnosis exercise and mortality risk in cancer survivors |
Jessica Gorzelitz |
University of Iowa |
PLCO |
Sep 6, 2022 |
PLCO-1032 |
| AI based Multi space findings detector for Chest radiograph |
Mohammed Amro |
Synthesis Health Intelligence Inc. |
PLCO |
Sep 6, 2022 |
PLCOI-1037 |
| Prostate specific antigen volatility and the diagnosis of clinically significant prostate cancer |
John Leppert |
Stanford University |
PLCO |
Aug 29, 2022 |
PLCO-1034 |
| Metabolic health phenotypes, accelerated biological aging and cancer risk. |
Prasoona Karra |
Geisel School of Medicine at Dartmouth College |
PLCO |
Aug 29, 2022 |
PLCO-1028 |
| Use of PLCO data to evaluate the performance of cancer risk models |
Thomas Ahearn |
Division of Cancer Genetics and Epidemiology, NCI |
PLCO |
Aug 22, 2022 |
PLCO-1025 |
| Data Analysis of Male Breast Cancer |
Vaidehi Gajera |
Western Sydney University |
PLCO |
Aug 22, 2022 |
PLCO-1029 |
